KR-31543 reduces the production of proinflammatory molecules in human endothelial cells and monocytes and attenuates atherosclerosis in mouse model

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse Model 100%
• Atherosclerosis 100%
• Anti-Inflammatory Drug 66%
• Reactive Oxygen Metabolite 33%
• Low Density Lipoprotein Receptor 33%
• Hydrogen Peroxide 33%
• High Density Lipoprotein Cholesterol 33%
• Triacylglycerol 33%
• Pentetrazole 33%
• Vascular Cell Adhesion Molecule 1 33%
• Atherogenesis 33%
• Neuroprotective Agent 33%
• Interleukin 6 33%

Immunology and Microbiology

• Mouse Model 100%
• Atherosclerosis 100%
• Macrophage 33%
• Hydrogen Peroxide 33%
• Blood Level 33%
• Interleukin 6 33%
• VCAM-1 33%
• Cholesterol Blood Level 33%
• Lipid Peroxidation 33%
• Interleukin 8 33%